VIA
KURA icon

Virtus Investment Advisers’s Kura Oncology KURA Stock Holding History

Virtus Investment Advisers’s Portfolio KURA Stock Details KURA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.41M Buy
128,495
+45,885
+56% +$433K 0.33% 134
2026
Q1 		$672K Buy
82,610
+15,740
+24% +$135K 0.19% 183
2025
Q4 		$695K Buy
66,870
+49,785
+291% +$522K 0.19% 169
2025
Q3 		$151K Buy
17,085
+2,966
+21% +$21.1K 0.04% 374
2025
Q2 		$81.5K Sell
14,119
-2,823
-17% -$17.3K 0.03% 417
2025
Q1 		$112K Buy
+16,942
New +$132K 0.03% 404

Other funds holding KURA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
ACM
Alethea Capital Management Mercer Island, Washington $241M AUM 112.74% 1-Year Est. Return

Virtus Investment Advisers's KURA Position: Q2 2026 in Review

Virtus Investment Advisers increased its Kura Oncology (KURA) stake by 56% in Q2 2026, buying an estimated $433K and bringing the position to 128,495 shares worth $1.41M. The position accounts for 0.33% of the portfolio, ranked #134.

Virtus Investment Advisers first reported a position in KURA in Q1 2025 and has held it in 6 quarters since. 221 funds tracked by Wall St. Rank hold KURA as of Q2 2026.

  • Virtus Investment Advisers held 128,495 shares of Kura Oncology worth $1.41M as of Q2 2026.
  • Virtus Investment Advisers bought 45,885 Kura Oncology shares in Q2 2026, an estimated $433K.
  • Kura Oncology made up 0.33% of Virtus Investment Advisers's portfolio in Q2 2026, its #134 holding.
  • Virtus Investment Advisers first reported a position in Kura Oncology in Q1 2025 and has held it in 6 quarters since.
  • 221 funds tracked by Wall St. Rank held Kura Oncology as of Q2 2026.

Based on Virtus Investment Advisers's 13F filing for Q2 2026, filed 11 Aug 2026.